Health Products

Pulmicort Nebuamp - (0.125 mg/mL, 0.25 mg/mL, 0.5 mg/mL)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
WT0023, AC0180, AN0086B. Pulmicort Nebuamp 0.25 mg/mL
Recalling Firm
AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
Marketing Authorization Holder
AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
2 mL ampoulesDIN 019789180.25 mg/mL
AB0126C. Pulmicort Nebuamp  0.5 mg/mL
Recalling Firm
AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
Marketing Authorization Holder
AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
2 mL ampoulesDIN 019789260.5 mg/mL
YM0042A. Pulmicort Nebuamp 0.125 mg/mL
Recalling Firm
AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
Marketing Authorization Holder
AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
2 ml ampoulesDIN 022290990.125 mg/mL

Introduction

Recalled Products

Pulmicort Nebuamp - 0.125 mg/mL, 0.25 mg/mL, 0.5 mg/mL

Reason

Budesonide content in a small number of ampoules may be above or below the specification range.

Depth of distribution

Retailers nationwide
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime